Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
09-Apr-2025 | 1,094.5 | 1,103.25 | 1,061.65 | 1,094.05 | 1,17,243 | 6,01,49,46,285.75 | 38,90,569 |
11-Apr-2025 | 1,139.9 | 1,139.9 | 1,102.25 | 1,109.5 | 91,866 | 3,06,89,04,560.9 | 17,18,578 |
15-Apr-2025 | 1,140.9 | 1,158.1 | 1,129 | 1,154.9 | 72,640 | 3,07,68,69,271.1 | 16,90,775 |
16-Apr-2025 | 1,150.2 | 1,161.4 | 1,143.7 | 1,158.4 | 77,501 | 1,67,50,01,335.4 | 8,65,945 |
17-Apr-2025 | 1,150.1 | 1,173.6 | 1,150.1 | 1,163.6 | 72,694 | 3,24,75,79,205.9 | 18,10,430 |
21-Apr-2025 | 1,163.4 | 1,179.7 | 1,155 | 1,177.4 | 66,564 | 2,26,80,03,614.4 | 12,77,733 |
22-Apr-2025 | 1,173.9 | 1,180.5 | 1,162.3 | 1,175 | 42,491 | 1,54,17,16,008 | 6,74,285 |
23-Apr-2025 | 1,185.1 | 1,191.8 | 1,175.9 | 1,186 | 82,010 | 3,77,92,09,145.2 | 22,05,655 |
24-Apr-2025 | 1,179 | 1,210 | 1,176.3 | 1,200.5 | 80,333 | 5,76,26,72,667.5 | 29,94,390 |
25-Apr-2025 | 1,203.9 | 1,210.5 | 1,159.7 | 1,174.8 | 51,311 | 1,51,64,30,178 | 5,59,888 |
28-Apr-2025 | 1,176.3 | 1,205 | 1,176.3 | 1,198.7 | 57,178 | 1,47,99,79,904.7 | 5,52,671 |
29-Apr-2025 | 1,204.4 | 1,204.4 | 1,169 | 1,176 | 71,628 | 1,96,02,85,386.8 | 8,17,817 |
30-Apr-2025 | 1,176.2 | 1,196.6 | 1,175.9 | 1,183.9 | 63,580 | 1,90,21,02,797.3 | 9,39,467 |
02-May-2025 | 1,176.1 | 1,194.8 | 1,171.4 | 1,182.9 | 55,170 | 1,54,40,77,141.5 | 6,49,140 |
05-May-2025 | 1,188.7 | 1,193.9 | 1,154.5 | 1,171.3 | 55,068 | 2,21,28,41,386.4 | 9,95,679 |
06-May-2025 | 1,172.2 | 1,175 | 1,129.4 | 1,160.4 | 60,270 | 2,30,55,78,118.9 | 10,37,443 |
07-May-2025 | 1,143.4 | 1,164.6 | 1,143.4 | 1,160.7 | 60,034 | 1,64,73,87,239.1 | 8,95,326 |
08-May-2025 | 1,152.7 | 1,161.4 | 1,142 | 1,148 | 99,397 | 3,00,86,38,014.5 | 14,65,472 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.
Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore.
The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.
Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.
Here are some of the stocks that may see significant price movement today: Dr Reddy’s Laboratories, RITES, Canara Bank, etc.
Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in 2023.
Dr Reddy’s Laboratories shares has gained a total of 5.62% in the last one year, and 2.45% since the beginning of the year.
Here are some of the stocks that may see significant price movement today: UPL, Tata Power, JSW Steel, Dr Reddy’s, etc.
EBITDA for the quarter increased 5% year-on-year to ₹2,280 Crore between July and September 2024, while margins improved modestly to 28.4%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
